Article Text


1124 Levosimendan Rescue Therapy in Non-Cardiosurgical Neonates with Heart Failure: a Case Series
  1. A Tempera1,
  2. M Piastra2,
  3. E Luca2,
  4. G De Rosa3,
  5. E Buffone1,
  6. G Conti2,
  7. MP De Carolis4
  1. 1Neonatal ICU, S.Camillo-Forlanini Hospital
  2. 2Emergency Department, Pediatric ICU
  3. 3Pediatric Cardiology, Department of Pediatrics
  4. 4Neonatal ICU, Department of Pediatrics, Catholic University of the Sacred Heart, A. Gemelli Hospital, Roma, Italy


Background and Aims To report the successful use of the new inodilator levosimendan in 4 critically ill neonates with refractory heart failure. At present, no data are available on the use of levosimendan in newborns outside the cardiosurgical setting.

Methods Clinical chart review.

Results Neonates described in Table 1 were given LS due to severe refractory heart failure when standard treatment was ineffective and/or complications occurred. LS was administered as a continuous i.v. infusion (0.2 mcg/kg/min over the first 24 hrs). LS addition resulted in an improvement and/or stabilisation of hemodynamic status, with nearly normal restoration of heart function in 2/4 infants. Patients with PH and RV enlargement could be weaned off from pulmonary vasodilators.

Conclusions In these full-term neonates with post-ischaemic low cardiac output/pulmonary hypertension and heart failure of infectious or metabolic origin, refractory to first line inotropic drugs, LS was a potent inotropic agent and a possible add-on therapy. As suggested, in the neonatal period LS may represent an ideal drug for immature myocardium characterized by a much more calcium dependent contractility than adults. Further studies are needed to evaluate the role of LS in refractory HF.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.